Established 1999
 
8,000 companies from
USA,Canada and India.		  
   
Search over 25,000 News & Earnings Archives    
 

DrugAbuse Sciences, Inc.(DASI)

 
123Jump Rating:   Underwriters: Warburg Dillon Read LLC
      Robertson, Stephens & Company
Status:  
 
Address: 1430 O'Brien Drive
 FiledDate:
     
  Filed Price Range ($):
       
Telephone: (650) 462-1000 Filed Offer Amount ($ Million): $0.00
       
Fax: (650) 462-1003 Shares Offered (Millions): 4,000,000
       
Websites: Shares Outstanding (Millions): 16,502,131
       
Management: Philippe Pouletty, Chairman/CEO
 IPO Date:
  Elizabeth M. Greetham, SVP/CFO
    
  Final Offer Price ($): $0.00
       
Industry: Final Offer Size (Millions of Shares): 0.00
       
Employees: 19 Final Offer Amount ($ Million): $0.00
       
Competitors: Dupont Merck
 S-1 Forms:
  Medimmune
    
  Schering-Pough
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1995 0.00 254.55 -254.55 0.00 -254.55 -.13
1996 0.00 299.56 -299.56 0.00 -292.91 -.14
1997 0.00 1382.41 -1382.41 0.00 -1300.16 -.6
1998 810.6 2083.55 -1272.94 0.00 -1192.34 -.56
1999 1224.6 7603.65 -6379.05 0.00 -6228 -7.45
 
 
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
© 1999-2008 123jump.com. All rights reserved